These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19116148)

  • 1. Identification of a novel point mutation in ENT1 that confers resistance to Ara-C in human T cell leukemia CCRF-CEM cells.
    Zimmerman EI; Huang M; Leisewitz AV; Wang Y; Yang J; Graves LM
    FEBS Lett; 2009 Jan; 583(2):425-9. PubMed ID: 19116148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-expression profiling reveals down-regulation of equilibrative nucleoside transporter 1 (ENT1) in Ara-C-resistant CCRF-CEM-derived cells.
    Takagaki K; Katsuma S; Kaminishi Y; Horio T; Nakagawa S; Tanaka T; Ohgi T; Yano J
    J Biochem; 2004 Nov; 136(5):733-40. PubMed ID: 15632314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of equilibrative nucleoside transporter 1 (ENT1) in the disposition of cytarabine in mice.
    Anderson JT; Hu S; Fu Q; Baker SD; Sparreboom A
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00534. PubMed ID: 31832201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells.
    Cai J; Damaraju VL; Groulx N; Mowles D; Peng Y; Robins MJ; Cass CE; Gros P
    Cancer Res; 2008 Apr; 68(7):2349-57. PubMed ID: 18381442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FLT3-ITD induces ara-C resistance in myeloid leukemic cells through the repression of the ENT1 expression.
    Jin G; Matsushita H; Asai S; Tsukamoto H; Ono R; Nosaka T; Yahata T; Takahashi S; Miyachi H
    Biochem Biophys Res Commun; 2009 Dec; 390(3):1001-6. PubMed ID: 19853583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorouracil uptake in triple-negative breast cancer cells: Negligible contribution of equilibrative nucleoside transporters 1 and 2.
    Noguchi S; Takagi A; Tanaka T; Takahashi Y; Pan X; Kibayashi Y; Mizokami R; Nishimura T; Tomi M
    Biopharm Drug Dispos; 2021 Mar; 42(2-3):85-93. PubMed ID: 33426680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine.
    SenGupta DJ; Lum PY; Lai Y; Shubochkina E; Bakken AH; Schneider G; Unadkat JD
    Biochemistry; 2002 Feb; 41(5):1512-9. PubMed ID: 11814344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1.
    Hammond JR; Stolk M; Archer RG; McConnell K
    Eur J Pharmacol; 2004 Apr; 491(1):9-19. PubMed ID: 15102528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular Uptake of Decitabine by Equilibrative Nucleoside Transporters in HCT116 Cells.
    Ueda K; Hosokawa M; Iwakawa S
    Biol Pharm Bull; 2015; 38(8):1113-9. PubMed ID: 26235575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
    Hammond JR
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning of a novel isoform of the mouse NBMPR-sensitive equilibrative nucleoside transporter (ENT1) lacking a putative phosphorylation site.
    Handa M; Choi DS; Caldeiro RM; Messing RO; Gordon AS; Diamond I
    Gene; 2001 Jan; 262(1-2):301-7. PubMed ID: 11179696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrobenzylthioinosine (NBMPR) binding and nucleoside transporter ENT1 mRNA expression after prolonged wakefulness and recovery sleep in the cortex and basal forebrain of rat.
    Alanko L; Stenberg D; Porkka-Heiskanen T
    J Sleep Res; 2003 Dec; 12(4):299-304. PubMed ID: 14633241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human erythrocyte nucleoside transporter ENT1 functions at ice-cold temperatures.
    Takano M; Kimura E; Suzuki S; Nagai J; Yumoto R
    Drug Metab Pharmacokinet; 2010; 25(4):351-60. PubMed ID: 20814156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model.
    Paproski RJ; Wuest M; Jans HS; Graham K; Gati WP; McQuarrie S; McEwan A; Mercer J; Young JD; Cass CE
    J Nucl Med; 2010 Sep; 51(9):1447-55. PubMed ID: 20720035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis.
    Macanas-Pirard P; Leisewitz A; Broekhuizen R; Cautivo K; Barriga FM; Leisewitz F; Gidi V; Riquelme E; Montecinos VP; Swett P; Besa P; Ramirez P; Ocqueteau M; Kalergis AM; Holt M; Rettig M; DiPersio JF; Nervi B
    PLoS One; 2012; 7(5):e37203. PubMed ID: 22629369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome.
    Macanas-Pirard P; Broekhuizen R; González A; Oyanadel C; Ernst D; García P; Montecinos VP; Court F; Ocqueteau M; Ramirez P; Nervi B
    Oncotarget; 2017 Apr; 8(14):23073-23086. PubMed ID: 28160570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine residues in the transmembrane (TM) 9 to TM11 region of the human equilibrative nucleoside transporter subtype 1 play an important role in inhibitor binding and translocation function.
    Park JS; Hammond JR
    Mol Pharmacol; 2012 Nov; 82(5):784-94. PubMed ID: 22837314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex effects of sulfhydryl reagents on ligand interactions with nucleoside transporters: evidence for multiple populations of ENT1 transporters with differential sensitivities to N-ethylmaleimide.
    Vyas S; Ahmadi B; Hammond JR
    Arch Biochem Biophys; 2002 Jul; 403(1):92-102. PubMed ID: 12061806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cysteines involved in the effects of methanethiosulfonate reagents on human equilibrative nucleoside transporter 1.
    Park JS; Hughes SJ; Cunningham FK; Hammond JR
    Mol Pharmacol; 2011 Oct; 80(4):735-46. PubMed ID: 21791574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.